Spirogyra neglecta (Hassall) Kueurotzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway

被引:5
|
作者
Arjsri, Punnida [1 ]
Phetcharaburanin, Jutarop [2 ,3 ]
Suksawat, Manida [2 ,3 ]
Mapoung, Sariya [1 ,5 ]
Subkamkaew, Chayaporn [1 ]
Semmarath, Warathit [1 ]
Yodkeeree, Supachai [1 ,4 ,5 ]
Limtrakul Dejkriengkraikul, Pornngarm [1 ,4 ,5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand
[2] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand
[3] Khon Kaen Univ, Int Phenome Lab, Northeastern Sci Pk, Khon Kaen, Thailand
[4] Chiang Mai Univ, Ctr Res & Dev Nat Prod Hlth, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Anticarcinogenesis & Apoptosis Res Cluster, Chiang Mai, Thailand
关键词
Spirogyra neglecta; Prostate cancer; Herbal extracts; Metabolomics; Anti-metastasis; Akt signaling; SPIRULINA-PLATENSIS; PROGRESSION; IDENTIFICATION; ANTIOXIDANT; EXTRACT; ALGA;
D O I
10.1016/j.sajb.2021.02.005
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Spirogyra neglecta (Hassall) Kutzing, a filamentous fresh water green alga, has clearly demonstrated its anti inflammation properties; however, the anti-metastasis activity of this plant has not yet been elucidated. This study aimed to investigate the anti-metastasis effects of S. neglecta against castration-resistant prostate cancer cells. Transwell assays were used to determine the anti-metastasis properties of S. neglecta against PC3 cells. Furthermore, the metabolic profiling, H-1-NMR based metabolomics analysis, was conducted to identify the potential active compounds. The results revealed that S. neglecta ethanolic extract (SnEE) significantly inhibited PC3 cells invasion and migration. The metabolomics for the profiling-based screening of very wellknown medicinal herbs in Asian countries (S. neglecta, S. platensis, T. erecta, C. siamea) have indicated a significant positive association between gallic acid, gentisic acid and the anti-metastasis properties of the SnEE. Thus, the solvent-partition technique was performed to concentrate the phenolic compounds in SnEE and then to establish the S. neglecta ethyl acetate fraction (SnEA). Mechanistically, SnEA inhibited PC3 cells metastasis through the inhibition of MMP-9 secretion, epithelial-mesenchymal transition, and the Akt signaling pathway (p<0.01). Our study, for the first time, showed that S. neglecta extract displayed remarkable anti metastasis properties against castration-resistant prostate cancer by inhibiting the Akt signaling pathway. These findings appeared to support the use of S. neglecta extract as a natural supplement in the effective treatment of prostate cancer. (C) 2021 SAAB. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 37
页数:12
相关论文
共 50 条
  • [1] Pyrogallol from Spirogyra neglecta Inhibits Proliferation and Promotes Apoptosis in Castration-Resistant Prostate Cancer Cells via Modulating Akt/GSK-3β/β-catenin Signaling Pathway
    Arjsri, Punnida
    Mapoung, Sariya
    Semmarath, Warathit
    Srisawad, Kamonwan
    Tuntiwechapikul, Wirote
    Yodkeeree, Supachai
    Dejkriengkraikul, Pornngarm
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [2] Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer
    Rafiei, Shahrzad
    Gui, Bin
    Wu, Jiaxin
    Liu, X. Shirley
    Kibel, Adam S.
    Jia, Li
    MOLECULAR CANCER RESEARCH, 2019, 17 (01) : 263 - 276
  • [3] Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling
    Huang, Shih-Han
    Tseng, Jen-Chih
    Lin, Ching-Yu
    Kuo, Ying-Yu
    Wang, Bi-Juan
    Kao, Yung-Hsi
    Muller, Christo J. F.
    Joubert, Elizabeth
    Chuu, Chih-Pin
    PHYTOMEDICINE, 2019, 64
  • [4] Predictors of Time to Metastasis in Castration-resistant Prostate Cancer
    Moreira, Daniel M.
    Howard, Lauren E.
    Sourbeer, Katharine N.
    Amarasekara, Hiruni S.
    Chow, Lydia C.
    Cockrell, Dillon C.
    Hanyok, Brian T.
    Aronson, William J.
    Kane, Christopher J.
    Terris, Martha K.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Liede, Alex
    Freedland, Stephen J.
    UROLOGY, 2016, 96 : 171 - 176
  • [5] Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
    Floc'h, Nicolas
    Kinkade, Carolyn Waugh
    Kobayashi, Takashi
    Aytes, Alvaro
    Lefebvre, Celine
    Mitrofanova, Antonina
    Cardiff, Robert D.
    Califano, Andrea
    Shen, Michael M.
    Abate-Shen, Cory
    CANCER RESEARCH, 2012, 72 (17) : 4483 - 4493
  • [6] Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
    Floc'h, Nicola
    Kinkade, Carolyn Waugh
    Kobayashi, Takashi
    Aytes, Alvaro
    Lefebvre, Celine
    Mitrofanova, Antonina
    Cardiff, Robert D.
    Califano, Andrea
    Shen, Michael M.
    Abate-Shen, Cory
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
    Nickerson, Michael L.
    Im, Kate M.
    Misner, Kevin J.
    Tan, Wei
    Lou, Hong
    Gold, Bert
    Wells, David W.
    Bravo, Hector C.
    Fredrikson, Karin M.
    Harkins, Timothy T.
    Milos, Patrice
    Zbar, Berton
    Linehan, W. Marston
    Yeager, Meredith
    Andresson, Thorkell
    Dean, Michael
    Bova, G. Steven
    HUMAN MUTATION, 2013, 34 (09) : 1231 - 1241
  • [8] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
    Bitting, Rhonda L.
    Armstrong, Andrew J.
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : R83 - R99
  • [9] The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway
    Bai, Shoumin
    Chen, Ting
    Yu, Xiaoli
    Lu, Ming
    Chen, Xianju
    Lin, Chunhao
    Lai, Yiming
    Huang, Hai
    ONCOLOGY REPORTS, 2017, 37 (05) : 2819 - 2828
  • [10] Efficacy of androgen signaling blockade in castration-resistant prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (10): : 523 - 524